Article Figures & Data
Tables
- Table 1
Significant differences between the groups regarding laboratory findings of serum zinc and copper only N=90).
Laboratory findings Cases Controls t-test P-value (mean± standard deviation) Copper 180.1±32.4 114.5±18.5 7.245 <0.001** Zinc 60.1±22.6 102.1±18 6.262 <0.001** Total bilirubin 0.5±0.2 0.4±0.1 1.212 0.232 SGOT 28.3±12 29.1±11 0.07 0.789 SGPT 38.2±10 37.4±12 0.08 0.78 Albumin 3.9±0.5 4±0.5 0.431 0.668 Total protein 6.8±2 7.9±3 2.79 0.099 Urea 30.8±6.8 27.3±4 1.82 0.076 Creatinine 0.6±0.1 0.5±0.1 1.348 0.06 SGOT - serum glutamic-oxaloacetic yransaminase, SGPT - serum glutamic-pyruvic transaminase,
↵** p>0.05 were statistically significant
- Table 2
Type of seizure, type of treatment, and response to treatment based on gender (N=90).
Convulsion Gender X2 P-value Male n=63 Female n=27 n (%) Type of seizure Generalized 45 (71.4) 24 (88.9) 1.07 0.3 Partial 18 (28.6) 3 (11.1) Type of response to treatment Non responder 12 (19.1) 6 (22.2) 0.04 0.979 Moderate responder 36 (57.1) 15 (55.6) Complete responder 15 (23.8) 6 (22.2) Type of treatment Single drug 18 (28.6) 15 (55.6) 1.98 0.159 Multiple drugs 45 (71.4) 12 (44.4) Laboratory findings Response to treatment F P-value Non responder Moderate responder Complete responder (mean± standard deviation) Copper 167.2±31 175±26.7 184.7±24.4 0.603 0.561 Zinc 73.8±33.4 57±24.3 58.2±8.2 0.863 0.443 Total bilirubin 0.4±0.2 0.5±0.1 0.4±0.2 0.505 0.614 SGOT 28±7.2 29±6.9 28.2±8.9 0.025 0.975 SGPT 35.5±5.6 38.6±5.4 39.8±5.6 0.968 0.404 Albumin 3.8±0.4 3.9±0.5 4.2±0.6 0.699 0.514 Total protein 6.7±0.2 6.9±0.4 6.7±0.2 0.825 0.601 Urea 30.3±5.5 32.8±5.8 7.7±3.1 0.198 0.822 Creatinine 0.6±0.2 0.6±0.1 0.5±0.1 0.345 0.714 SGOT - serum glutamic-oxaloacetic yransaminase,
SGPT - serum glutamic-pyruvic transaminaseSerum level Sodium valporate n=27 Carbamazepine n=12 T-test P-value Mean±SD Serum Zinc 65±0.05 52±8.1 5.58 0.024 Serum Copper 144.7±8 195±11 9.47 0.004
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.